Cargando…

Screening for Retinopathy of Prematurity in South of Iran

PURPOSE: The purpose of this study is to report the screening data for retinopathy of prematurity (ROP) at a screening center in Southern Iran. MATERIALS AND METHODS: A chart review was performed of all screened neonates who were referred to Poostchi screening center affiliated to Shiraz University...

Descripción completa

Detalles Bibliográficos
Autores principales: Afarid, Mehrdad, Hosseini, Hamid, Abtahi, Bagher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401795/
https://www.ncbi.nlm.nih.gov/pubmed/22837619
http://dx.doi.org/10.4103/0974-9233.97922
_version_ 1782238657309048832
author Afarid, Mehrdad
Hosseini, Hamid
Abtahi, Bagher
author_facet Afarid, Mehrdad
Hosseini, Hamid
Abtahi, Bagher
author_sort Afarid, Mehrdad
collection PubMed
description PURPOSE: The purpose of this study is to report the screening data for retinopathy of prematurity (ROP) at a screening center in Southern Iran. MATERIALS AND METHODS: A chart review was performed of all screened neonates who were referred to Poostchi screening center affiliated to Shiraz University of Medical Sciences from February 2006 to January 2010. Statistical analysis of data was performed with the Chi-square and independent t-test where appropriate. A P < 0.05 was considered statistically significant. RESULTS: Of 787 infants referred, 293 (37.2%) had some form of ROP and 77 cases (9.8%) had plus disease, only 6 (2%) patients progressed to advanced ROP stages 4 and 5. The mean gestational age (GA) of patients with ROP (ROP group) was statistically significantly lower at 29.46 ± 2.31 weeks compared to patients without ROP (non-ROP group) (31.56 ± 2.03 weeks) (P < 0.05). The mean GA of patients with plus disease was statistically significantly lower at 28.92 ± 2.18 weeks compared to patients without plus disease (30.98 ± 2.30 weeks) (P < 0.05). The mean birth weight in the ROP group was statistically significantly lower at 1248.46 ± 301.75 g compared to the non-ROP group (1485.79 ± 268.66 g) (P < 0.05). The mean birth weight of patients with plus disease was statistically significantly lower at 1207.92 ± 334.79 g compared to patients without plus disease (417.99 ± 293.19 g) (P < 0.05). There was no difference in the occurrence of ROP or plus disease between single or multiple births, normal vaginal delivery, and caesarian section and between clomiphene users and nonusers (P > 0.05, all cases). CONCLUSION: Greater cooperation between ophthalmologists, neonatologists, gynecologists, and health policy makers is necessary to optimize ROP screening programs. Data from this study can be used by health policy makers for implementation of health programs. These programs must include screening guidelines and effective coordination among the screening centers, antenatal, obstetric, and neonatal care services.
format Online
Article
Text
id pubmed-3401795
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-34017952012-07-26 Screening for Retinopathy of Prematurity in South of Iran Afarid, Mehrdad Hosseini, Hamid Abtahi, Bagher Middle East Afr J Ophthalmol Original Article PURPOSE: The purpose of this study is to report the screening data for retinopathy of prematurity (ROP) at a screening center in Southern Iran. MATERIALS AND METHODS: A chart review was performed of all screened neonates who were referred to Poostchi screening center affiliated to Shiraz University of Medical Sciences from February 2006 to January 2010. Statistical analysis of data was performed with the Chi-square and independent t-test where appropriate. A P < 0.05 was considered statistically significant. RESULTS: Of 787 infants referred, 293 (37.2%) had some form of ROP and 77 cases (9.8%) had plus disease, only 6 (2%) patients progressed to advanced ROP stages 4 and 5. The mean gestational age (GA) of patients with ROP (ROP group) was statistically significantly lower at 29.46 ± 2.31 weeks compared to patients without ROP (non-ROP group) (31.56 ± 2.03 weeks) (P < 0.05). The mean GA of patients with plus disease was statistically significantly lower at 28.92 ± 2.18 weeks compared to patients without plus disease (30.98 ± 2.30 weeks) (P < 0.05). The mean birth weight in the ROP group was statistically significantly lower at 1248.46 ± 301.75 g compared to the non-ROP group (1485.79 ± 268.66 g) (P < 0.05). The mean birth weight of patients with plus disease was statistically significantly lower at 1207.92 ± 334.79 g compared to patients without plus disease (417.99 ± 293.19 g) (P < 0.05). There was no difference in the occurrence of ROP or plus disease between single or multiple births, normal vaginal delivery, and caesarian section and between clomiphene users and nonusers (P > 0.05, all cases). CONCLUSION: Greater cooperation between ophthalmologists, neonatologists, gynecologists, and health policy makers is necessary to optimize ROP screening programs. Data from this study can be used by health policy makers for implementation of health programs. These programs must include screening guidelines and effective coordination among the screening centers, antenatal, obstetric, and neonatal care services. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3401795/ /pubmed/22837619 http://dx.doi.org/10.4103/0974-9233.97922 Text en Copyright: © Middle East African Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Afarid, Mehrdad
Hosseini, Hamid
Abtahi, Bagher
Screening for Retinopathy of Prematurity in South of Iran
title Screening for Retinopathy of Prematurity in South of Iran
title_full Screening for Retinopathy of Prematurity in South of Iran
title_fullStr Screening for Retinopathy of Prematurity in South of Iran
title_full_unstemmed Screening for Retinopathy of Prematurity in South of Iran
title_short Screening for Retinopathy of Prematurity in South of Iran
title_sort screening for retinopathy of prematurity in south of iran
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401795/
https://www.ncbi.nlm.nih.gov/pubmed/22837619
http://dx.doi.org/10.4103/0974-9233.97922
work_keys_str_mv AT afaridmehrdad screeningforretinopathyofprematurityinsouthofiran
AT hosseinihamid screeningforretinopathyofprematurityinsouthofiran
AT abtahibagher screeningforretinopathyofprematurityinsouthofiran